FindTrial
Sign In

To assess the incidence of six weeks mortality in cirrhotic patients after an episode of Acute Variceal Bleeding

Assessment of six weeks mortality after Acute Variceal Bleeding in Cirrhotic patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069589
Enrollment
400
Registered
2024-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K77- Liver disorders in diseases classified elsewhere Health Condition 2: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: NIL: NIL

Sponsors

Institute Of Post Graduate Medical Education and Research Centre IPGMERSSKM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with portal hypertension presenting with acute Esophageal variceal hemorrhage secondary to cirrhosis of liver presenting within 24 h of the onset of the bleeding will be enrolled in the study and followed for a period of 6 week

Exclusion criteria

Exclusion criteria: 1. Patients less than 18 years of age 2. Patients with isolated gastric varix or GOV2 will be excluded from our study 3.Patients with non-cirrhotic portal hypertension will be excluded from our study

Design outcomes

Primary

MeasureTime frame
To assess 6 weeks mortality of cirrhotic patients presenting with acute variceal bleedTimepoint: Six weeks from the Time of Admission to Hospital—

Secondary

MeasureTime frame
To Assess the Risk factors assosiated with Variceal Rebleeding within 6 weeks Timepoint: 6 weeks—

Countries

India

Contacts

Public ContactKOELINA SIL

IPGMER/SSKM HOSPITAL

skmahiuddinahammed@gmail.com9051157404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026